Autopsy report · NCT01230970

Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast Cancer

Cause of deathFutility Automatic label, confidence 0.9, unverified. How labels are made.

“The futility analysis of study NCT00910091 in patients with endometrial cancer shows that the primary endpoint will not be reached.”

The sponsor’s own words in the registry.

Life of this trial

Registered 7 months before it started.
Ran for about 0 months before it stopped.
2 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Ipsen
Sponsor type: Industry
Conditions: Breast Cancer
Interventions: BN83495
Participants: 2
Sites: 1
Countries: Norway

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.